Notice2022-08779
Submission for OMB Review; 30-Day Comment Request International Research Fellowship Award Program of the National Institute on Drug Abuse (NIDA)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 25, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
In compliance with the Paperwork Reduction Act of 1995, the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 79 (Monday, April 25, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 79 (Monday, April 25, 2022)]
[Notices]
[Pages 24323-24324]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-08779]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request International
Research Fellowship Award Program of the National Institute on Drug
Abuse (NIDA)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institute on Drug Abuse (NIDA), National Institutes of Health
(NIH) has submitted to the Office of Management and Budget (OMB) a
request for review and approval of the information collection listed
below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Lindsey Friend, Research Training Program
Officer, NIDA International Program, National Institute on Drug Abuse,
National Institutes of Health, 3WFN MSC 6024, 301 North Stonestreet
Avenue, Bethesda, Maryland 20892, or call non-toll-free number (301)
402-1428 or email your request, including your address to:
<a href="/cdn-cgi/l/email-protection#b7dbded9d3c4d2ce99d1c5ded2d9d3f7d9dedf99d0d8c1"><span class="__cf_email__" data-cfemail="284441464c5b4d51064e5a414d464c68464140064f475e">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on February 14, 2022, page
8267 (87 FR 8267) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment.
The National Institute on Drug Abuse (NIDA), National Institutes of
Health, may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: The International Research Fellowship Award
Program of the National Institute on Drug Abuse (NIDA), 0925-0733,
expiration date 07/31/2022, EXTENSION, National Institute on Drug Abuse
(NIDA), National Institutes of Health (NIH).
Need And Use of Information Collection: These programs offer grants
and traineeships necessary for growing the biomedical researcher
workforce, and the diversity in this workforce. The application forms
collect information of applicants for selecting those that would
benefit most effectively from the programs. NIDA is requesting approval
from OMB for application forms to be used by these programs that will
recruit pre-college through post-doctoral underrepresented individuals
and individuals of special populations into the research programs of
the Institute for research training and research development, for
forging mentor/mentee relationships and networking between newly funded
underrepresented researchers and experienced investigators funded by
NIDA; and for a fellowship program to train new researchers, and
support experienced researchers of other nations, in research to
advance the biomedical and behavioral science of drug abuse and
addiction while fostering multinational research in this disease area.
The application forms will be web-based.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total annualized burden hours
are 33.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Applicant Scientists............................ 25 1 1 25
Scientists...................................... 25 1 20/60 8
---------------------------------------------------------------
Total....................................... .............. 50 .............. 33
----------------------------------------------------------------------------------------------------------------
[[Page 24324]]
Dated:April 20, 2022
Lanette A. Palmquist,
Project Clearance Liaison, National Institute on Drug Abuse, National
Institutes of Health.
[FR Doc. 2022-08779 Filed 4-22-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 25, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.